Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Inflammasome and Dysfunctional Adipose Tissue: Why Should apoB-lipoproteins be Targeted in Humans

NCT04496154 is registered in ClinicalTrials.gov with May Faraj, PDt, PhD as lead sponsor.

NCT NCT04496154
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04496154 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Inflammasome and Dysfunctional Adipose Tissue: Why Should apoB-lipoproteins be Targeted in Humans
Lead sponsor
May Faraj, PDt, PhD
Phase
Not applicable
Overall status
Completed
Start date
September 5, 2013
Completion date
February 24, 2020
Enrollment
41 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

fatty acids, omega-3, inflammatory response, insulin sensitivity/resistance, type 2 diabetes